Drug-Device Combination Market to Reach $30.5B by 2017

Spinal Tech

The drug-device combination market is expected to grow by 9.9 percent to $30.5 billion by 2017, said a report from BCC Research, according to Healthcare Packaging. The market was valued at $18.5 billion in 2011 and reached $19 billion in 2012.

The report also estimates 30 percent of all healthcare products currently under develop are combination devices with built-in pharmaceutical or biologic components.

Combination devices include orthopedic applications, coronary stents, photodynamic therapies and antimicrobial catheters.

More Articles on Devices:
Alphatec Spine Receives FDA Clearance for 2 Cervical, Fixation Devices
Zimmer Recall Labeled High Risk by FDA
Orthopedic Device Company DJO Global Acquires Exos Corp


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers